Free Trial

Straumann (SAUHF) Projected to Post Quarterly Earnings on Wednesday

Straumann logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Straumann is expected to report quarterly results on Wednesday, April 29, with analysts forecasting $1.77 earnings per share and $1.5724 billion in revenue.
  • Shares were up about 1.8% and opened at $114.28, trading within a one‑year range of $93.18 to $139.59 and with 50‑day/200‑day moving averages of $110.70 and $115.45.
  • Straumann is a Swiss developer and manufacturer best known for dental implant systems and a broader portfolio of biomaterials, digital dentistry technologies, and practice/laboratory services.
  • Five stocks we like better than Straumann.

Straumann (OTCMKTS:SAUHF - Get Free Report) is expected to be issuing its resultson Wednesday, April 29th. Analysts expect the company to announce earnings of $1.77 per share and revenue of $1.5724 billion for the quarter.

Straumann Stock Up 1.8%

OTCMKTS:SAUHF opened at $114.28 on Wednesday. Straumann has a 1 year low of $93.18 and a 1 year high of $139.59. The business has a 50 day simple moving average of $110.70 and a 200-day simple moving average of $115.45.

About Straumann

(Get Free Report)

Straumann Group OTCMKTS: SAUHF is a Swiss-based developer and manufacturer of products and solutions for restorative and regenerative dentistry. The company is best known for its dental implant systems and related prosthetic components, and it has expanded its portfolio to include biomaterials, digital dentistry technologies, and practice- and laboratory-oriented services. Straumann positions itself as a provider of end-to-end solutions for clinicians, dental laboratories and dental practices aiming to restore oral function and aesthetics.

The Straumann product range covers titanium and ceramic implants, abutments, fixed and removable prosthetic solutions, bone grafting and regenerative materials, surgical instruments and guided-surgery systems.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Straumann Right Now?

Before you consider Straumann, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Straumann wasn't on the list.

While Straumann currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines